Key result
Higher remnant cholesterol variability is linked to ~16% greater all-cause mortality risk per SD.
Why the study?
Does higher remnant cholesterol variability increase the risk of all-cause and cardiovascular mortality in adults?
Cohort (n=6,650)
Does higher remnant cholesterol variability increase the risk of all-cause and cardiovascular mortality in adults?
Answers are grounded in this paper and cite their sources.
Higher variability in remnant cholesterol is independently associated with an increased risk of all-cause and cardiovascular mortality, suggesting its potential utility in cardiovascular risk stratification.
Background Few studies have addressed the relationship between remnant cholesterol (RC) and mortality outcomes. However, the influence of variability in RC with mortality is understudied. Purpose To evaluate the independent association of RC variability with all-cause and cardiovascular mortality in a large, community-based longitudinal cohort. Methods Adults ≥30 years from the Tehran Lipid and Glucose Study (TLGS) with ≥2 RC measurements during a median exposure time of 6.2 years were included. RC was calculated as total cholesterol - HDL-C - LDL-C (estimated using Martin–Hopkins equations). RC variability was quantified using standard deviation (SD), variability independent of the mean (VIM), and average real variability (ARV). The primary outcomes were all-cause mortality and cardiovascular mortality. Cox models with adjustments for age, sex, LDL-C, HDL-C, diabetes, eGFR, BMI, waist circumference, blood pressure, smoking, physical activity, education, marital status, antihypertensive and lipid-lowering medications, were applied. Multiple imputations were performed to account for missing values. As a sensitivity analysis, we excluded deaths within the first 2 years of follow-up to address the potential role of reverse causation in the main findings. Results A total of 6650 participants (mean age 54.1 years; 62% women) were included over a median follow-up of 10.2 years after the exposure window. Higher variability of RC had a significant, robust association with increased risk of all-cause and cardiovascular mortality, independent of multiple confounders. Regarding the outcome of all-cause mortality, a greater RC variability (per 1-SD change) was accompanied by HRs of 1.16 (95% CI: 1.06-1.26; p= 0.001) and 1.12 (1.03-1.23; p=0.011) for SD and ARV, respectively. Moreover, the highest quartile of SD and ARV was associated with 52% (HR 1.52, 1.15-2.00) and 38% (HR 1.38, 1.05-1.81) higher mortality risk, respectively. A significant trend of increased risk across quartiles of SD and VIM was found (p-trends 0.005 and 0.018, respectively). Consistent results but with a higher magnitude were found in regard to cardiovascular mortality, with 86% (HR 1.86, 1.25-2.76), 72% (HR 1.72, 1.17-2.54), and 49% (HR 1.49, 1.01-2.18) significant higher risk for participants in the highest quartile of SD, VIM, and ARV, compared to the lowest quartile, respectively. Moreover, a 1-SD increase in variability indices of SD and ARV was associated with HRs of 1.20 (1.08-1.34) and 1.14 (1.02-1.28). Notably, the results of sensitivity analysis excluding deaths within the first two years of follow-up remained essentially unchanged in line with the main findings. Conclusion Variability of RC is a risk factor for all-cause and cardiovascular mortality, independent of notable traditional risk factors including LDL-C and HDL-C. Incorporating RC variability in addition to a single measurement of RC may improve risk stratification.
No takes yet. Share an insight, caveat, or question.
Abdi et al. (2026) conducted a cohort in General population (n=6,650). Remnant cholesterol variability vs. Lower remnant cholesterol variability was evaluated on all-cause mortality (HR 1.16, 95% CI 1.06-1.26, p=0.001). Higher remnant cholesterol variability (per 1-SD change) was associated with an increased risk of all-cause mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: